No Man

Sign in

Join Free
Post RFQ

Icatibant acetate

TypeName: Business Offer

Category:

Offer Date:2019/08/10

Country: United States

Summary: Icatibant acetate is a selective antagonist of bradykinin B2 receptors. Icatibant is a medication approved for the treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.
https://www.bocsci.com/icatibant-acetate-cas-138614-30-9-item-185841.html

Description:

OfferId: 5152

Name:Alex Brown

Telphone:

Email:[email protected]